Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized open-label active-controlled study of voriconazole eye drops for fungal keratitis
CTR20250139Phase 2Active
- Sponsor
- Xingqi Eye Medicine
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of voriconazole in keratomycosis, sponsored by Xingqi Eye Medicine. Started Jan 2025; status: active.
02
Drugs
voriconazole
03
Conditions
keratomycosis
Beyond the preview
Go deeper on CTR20250139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250139.